Skip to main content
Watch Insiders
ROIV filings

Corporate insider profile

Eric Venker Filing Activity

Latest reported as President & Immunovant CEO of Roivant Sciences Ltd. (ROIV).

Purchase filings
0
Reported companies
2
Net open-market value
-$47,331,889.82
Latest transaction
Oct 20, 2026

Affiliated corporations

Reported company relationships

ROIVLatest reported

Roivant Sciences Ltd.

President & Immunovant CEO

IMVTPrior filing

Immunovant, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 20, 2026Roivant Sciences Ltd. (ROIV)President & Immunovant CEOSale200,000$35.11$7,022,660
Oct 2, 2026Immunovant, Inc. (IMVT)Chief Executive OfficerSale3,506$34.11$119,590
Sep 30, 2026Roivant Sciences Ltd. (ROIV)President & Immunovant CEOSale200,000$36.62$7,324,000
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium